DiCE is a partner in the HoloSurge project, which was awarded a Horizon Europe grant to improve surgical planning with hologram technology

One of the largest EU grants in recent history has been awarded to HoloSurge, an innovative four-year project bringing together 14 European leaders in technology and healthcare research with a shared goal to reduce the risk of complications during planned surgery. In order to achieve this goal, organ hologram technology, which was developed by Norwegian medtech company HoloCare, will be further refined to power informed surgical decision-making.

This technology provides liver surgeons with interactive 3D holograms of organs and is used by doctors to tailor operations to each person’s individual anatomy. This enables the planning of operations more efficiently and accurately, which can potentially reduce complications. The possibility of viewing the holograms remotely allows for the involvement of external specialists, which can ease decision-making during the planning process. The technology is initially being used for liver surgeries at five hospitals in Europe. Trials thus far show very positive results.^[1]

Over a four-year period, the 14 HoloSurge partners will support the integration of the hologram technology into existing surgical workflows. The team will ensure regulatory compliance, clinical validation, and technical optimisation for widespread adoption in liver and pancreatic cancer surgeries.

Prof David Jayne, Professor of Surgery at the University of Leeds and Hon. Consultant Surgeon at Leeds Teaching Hospitals NHS Trust shared very positive thoughts about the project: “The Holocare technology is an exciting advance in how we treat cancer patients with the potential to transform surgical care. The superior anatomical knowledge gained from the technology will enable more precise surgery with better cancer outcomes for patients”.

Jahn Otto, Innovation Director at HoloCare shared: “Innovation has long been the foundation for prosperity in Europe, from the breakthroughs improving healthcare to the technological advances growing our economy. In essence, Horizon Europe is not just about funding; it’s about forging connections, driving innovation, and shaping the future of healthcare. This not only opens doors for collaboration with the EU but also with Norway. The HoloSurge partnership stands as a testament to this. Through joint efforts with experts from the EU, UK and Norway, we’re aiming to use our hologram technology to transform the surgical outcomes of individuals worldwide. Our hope is that it can be adapted to benefit a wider range of surgeries in the future.”

As a partner in Work Package 10 (Dissemination, Exploitation, Communication), DiCE is looking forward to contributing to this exciting and highly relevant project over the next four years. Read the full press release.

---

[1] https://www.tandfonline.com/doi/full/10.1080/13645706.2019.1616558